About Index Trending news
Analyze
Top 50 Pricing
ViaCyte

ViaCyte

Work at ViaCyte? Add yourself to this profile

ViaCyte

Viacyte is a regenerative medicine company dedicated to improving the way diabetes patients are treated.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Grant
$3,900,000
Grant
$16,600,000
Employees

Team size

50+
Locations
HQ
$3,900,000 Grant
The San Diego Union-Tribune

CIRM grants ViaCyte $3.9 million for diabetes stem cell therapy

Xconomy

ViaCyte Reports on Stem Cell Diabetes Trial, Absorbs BetaLogics